Faro, Mònica, Sàez-Francás, Naia, Castro-Marrero, Jesús et al. · Reumatologia clinica · 2016 · DOI
Quick Summary
This study looked at differences between men and women diagnosed with ME/CFS, comparing 119 men with 1,190 women at the time of diagnosis. Men with ME/CFS tended to be younger, single, working in skilled jobs, and more commonly reported that an infection triggered their illness. Importantly, men reported less widespread pain, muscle symptoms, and other comorbid conditions than women, and reported better overall quality of life.
Why It Matters
ME/CFS is dramatically underrecognized in men, comprising only ~9% of diagnosed cases despite affecting both sexes. Understanding that men may present with a distinct clinical phenotype—including fewer pain symptoms and comorbidities—could improve diagnosis and prevent male patients from being overlooked or misdiagnosed. This knowledge helps researchers understand the biological and social factors driving gender differences in disease expression.
Observed Findings
Men comprised 9.1% of the ME/CFS cohort and had lower mean age and symptom onset than women.
Fibromyalgia was present in 29% of men versus 58% of women.
Men reported significantly lower rates of widespread pain, muscle spasms, dizziness, morning stiffness, and Raynaud's phenomenon.
Physical function and physical role SF-36 scores were higher in men than women.
Infection was the most common triggering factor for both genders.
Inferred Conclusions
Men with ME/CFS represent a distinct clinical phenotype characterized by younger age, fewer pain-dominant symptoms, and fewer immune-related comorbidities compared to women.
The lower prevalence of fibromyalgia in men suggests gender-related differences in symptom clustering or disease presentation.
Better quality of life scores in men at diagnosis may indicate either genuine differences in symptom burden or differential reporting and social role preservation.
Remaining Questions
Do these gender differences persist long-term, or do men's symptoms converge with women's over time?
What biological mechanisms (hormonal, immunological, genetic) explain the lower pain and comorbidity burden in men?
What This Study Does Not Prove
This study does not prove that men actually have milder disease—it only shows differences at one point in time (diagnosis). The better quality of life scores in men could reflect reporting bias, different pain perception, or social/occupational factors rather than genuinely less severe illness. The cross-sectional design cannot establish whether these differences persist over time or explain the biological mechanisms underlying gender differences.
Tags
Symptom:PainFatigueSensory Sensitivity
Phenotype:Infection-Triggered
Method Flag:Weak Case DefinitionStrong PhenotypingSex-Stratified